Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Juvista (Avotermin) in Breast Reduction Surgery Scars

This study has been terminated.
(Futility analysis undertaken, determined that study was underpowered.)
Sponsor:
Information provided by:
Renovo
ClinicalTrials.gov Identifier:
NCT00432328
First received: February 6, 2007
Last updated: January 12, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given